Study of INT-747 as Monotherapy in Patients With PBC

Update Il y a 5 ans
Reference: NCT00570765

Woman and Man

Extract

The primary hypothesis is that INT 747 will cause a reduction in alkaline phosphatase levels in PBC patients, over a 12 week treatment period, as compared to placebo.


Inclusion criteria

  • Liver Cirrhosis, Biliary